Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Quan, V. Sundararajan, P. Halfon, A. fong, B. Burnand, J. Luthi, L. Saunders, C. Beck, T. Feasby, W. Ghali (2005)
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative DataMedical Care, 43
S. Balducci, S. Zanuso, A. Nicolucci, P. Feo, S. Cavallo, P. Cardelli, S. Fallucca, E. Alessi, F. Fallucca, G. Pugliese (2010)
Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES).Archives of internal medicine, 170 20
J. McWilliams, E. Meara, A. Zaslavsky, J. Ayanian (2009)
Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare CoverageAnnals of Internal Medicine, 150
S. Ikramuddin, J. Korner, Wei-Jei Lee, J. Bantle, Avis Thomas, J. Connett, D. Leslie, W. Inabnet, Qi Wang, R. Jeffery, Keong Chong, L. Chuang, M. Jensen, A. Vella, Leaque Ahmed, K. Belani, Amy Olofson, H. Bainbridge, C. Billington (2016)
Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial, 39
V. Basevi (2011)
Diagnosis and Classification of Diabetes MellitusDiabetes Care, 34
(2016)
American Diabetes Association. 6. Obesity management for the treatment of type 2 diabetes
Ida Hatoum, R. Blackstone, T. Hunter, D. Francis, M. Steinbuch, Jason Harris, L. Kaplan (2016)
Clinical Factors Associated With Remission of Obesity-Related Comorbidities After Bariatric Surgery.JAMA surgery, 151 2
E. Spanakis, S. Golden (2013)
Race/Ethnic Difference in Diabetes and Diabetic ComplicationsCurrent Diabetes Reports, 13
A. Karter, S. Nundy, Melissa Parker, H. Moffet, E. Huang (2014)
Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging StudyDiabetes Care, 37
D. Ryan, M. Espeland, G. Foster, S. Haffner, V. Hubbard, K. Johnson, S. Kahn, W. Knowler, S. Yanovski (2003)
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.Controlled clinical trials, 24 5
S. Surbhi, I. Graetz, J. Wan, J. Gatwood, J. Bailey (2018)
The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in SuperutilizersJournal of Managed Care & Specialty Pharmacy, 24
Tennessee State Government Department of Health
S. Yanovski (2018)
Weight Management in Adults With Obesity: What Is a Primary Care Clinician to Do?JAMA, 320 11
Diabetes action report . Published 2019 . Updated February 28 , 2021
W. Hoelzel, C. Weykamp, J. Jeppsson, K. Miedema, John Barr, I. Goodall, Tadao Hoshino, W. John, U. Kobold, R. Little, A. Mosca, Pierluigi Mauri, Rita Paroni, Fransiscus Susanto, Izumu Takei, L. Thienpont, Masao Umemoto, H. Wiedmeyer (2004)
IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.Clinical chemistry, 50 1
I. Graetz, Jie Huang, Emilie Muelly, B. Fireman, J. Hsu, M. Reed (2020)
Association of Mobile Patient Portal Access With Diabetes Medication Adherence and Glycemic Levels Among Adults With Diabetes.JAMA network open, 3 2
J. Bailey, S. Surbhi, J. Wan, K. Munshi, T. Waters, Bonnie Binkley, Michael Ugwueke, I. Graetz (2019)
Effect of Intensive Interdisciplinary Transitional Care for High-Need, High-Cost Patients on Quality, Outcomes, and Costs: a Quasi-Experimental StudyJournal of General Internal Medicine, 34
P. Katzmarzyk, Corby Martin, R. Newton, J. Apolzan, C. Arnold, T. Davis, Kara Denstel, E. Mire, T. Thethi, P. Brantley, W. Johnson, V. Fonseca, J. Gugel, Kathleen Kennedy, C. Lavie, E. Price-Haywood, D. Sarpong, Benjamin Springgate (2018)
Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL): Rationale, design and baseline characteristics.Contemporary clinical trials, 67
P. Vijayakumar, R. Nelson, R. Hanson, W. Knowler, Madhumita Sinha (2016)
HbA1c and the Prediction of Type 2 Diabetes in Children and AdultsDiabetes Care, 40
C. Emdin, K. Rahimi, B. Neal, T. Callender, V. Perkovic, Anushka Patel (2015)
Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.JAMA, 313 6
G. Colditz, Walter Willett, A. Rotnitzky, J. Manson (1995)
Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in WomenAnnals of Internal Medicine, 122
A. Penman, W. Johnson (2006)
The Changing Shape of the Body Mass Index Distribution Curve in the Population: Implications for Public Health Policy to Reduce the Prevalence of Adult ObesityPreventing Chronic Disease, 3
T. Gary, Maura McGuire, J. Mccauley, F. Brancati (2004)
Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization.Disease management : DM, 7 1
Sharon Brown, Sandra Upchurch, R. Anding, Mary Winter, G. Ramirez (1996)
Promoting Weight Loss in Type II DiabetesDiabetes Care, 19
Edward Gregg, Haiying Chen, Lynne Wagenknecht, Jeanne Clark, L. Delahanty, J. Bantle, Henry Pownall, Karen Johnson, Monika Safford, Abbas Kitabchi, F. Pi-Sunyer, R. Wing, Alain Bertoni (2012)
Association of an intensive lifestyle intervention with remission of type 2 diabetes.JAMA, 308 23
A. Karter, Melissa Parker, H. Moffet, Ameena Ahmed, A. Ferrara, Jennifer Liu, J. Selby (2004)
Missed Appointments and Poor Glycemic Control: An Opportunity to Identify High-Risk Diabetic PatientsMedical Care, 42
C. MacDonald, Mette Johansen, S. Nielsen, R. Christensen, K. Hansen, H. Langberg, A. Vaag, K. Karstoft, D. Lieberman, B. Pedersen, M. Ried-Larsen (2020)
Dose-Response Effects of Exercise on Glucose-Lowering Medications for Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.Mayo Clinic proceedings
M. Huhmann, R. Cunningham (2005)
Importance of nutritional screening in treatment of cancer-related weight loss.The Lancet. Oncology, 6 5
(2016)
Obesity management for the treatment of type 2 diabetes
Diabetes Wellness and Prevention Coalition (DWPC)
E. Leblanc, Carrie Patnode, Elizabeth Webber, N. Redmond, M. Rushkin, Elizabeth O’Connor (2018)
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task ForceJAMA, 320
Qualified Health Plan Certification. Essential Community Providers and Network Adequacy
B. Smedley, Adrienne Stith, A. Nelson (2003)
Unequal treatment: confronting racial and ethnic disparities in health care.Journal of The National Medical Association, 94
J. Buse, S. Caprio, W. Cefalu, A. Ceriello, S. Prato, S. Inzucchi, S. Mclaughlin, G. Phillips, R. Robertson, F. Rubino, R. Kahn, M. Kirkman (2009)
How Do We Define Cure of Diabetes?Diabetes Care, 32
(2018)
Behavioralweight loss interventions to prevent obesity-relatedmorbidity and mortality in adults: us preventive services task force recommendation statement
M. Lean, W. Leslie, A. Barnes, N. Brosnahan, G. Thom, L. McCombie, C. Peters, S. Zhyzhneuskaya, A. Al-Mrabeh, K. Hollingsworth, Angela Rodrigues, L. Rehackova, A. Adamson, F. Sniehotta, J. Mathers, H. Ross, Y. McIlvenna, R. Stefanetti, M. Trenell, P. Welsh, S. Kean, I. Ford, A. McConnachie, N. Sattar, Roy Taylor (2017)
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trialThe Lancet, 391
R. Miech, Jinyoun Kim, Carrie McConnell, R. Hamman (2009)
A growing disparity in diabetes-related mortality U.S. trends, 1989-2005.American journal of preventive medicine, 36 2
M. Yoshino, B. Kayser, J. Yoshino, R. Stein, Dominic Reeds, J. Eagon, S. Eckhouse, J. Watrous, Mohit Jain, R. Knight, K. Schechtman, B. Patterson, S. Klein (2020)
Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes.The New England journal of medicine, 383 8
S. Surbhi, I. Brooks, S. Shuvo, Parya Zareie, Elizabeth Tolley, R. Cossman, Cardella Leak, R. Davis, A. Stewart, J. Bailey (2020)
A mid-South chronic disease registry and practice-based research network to address disparities.The American journal of managed care, 26 7
D. Sacks (2012)
Measurement of hemoglobin A(1c): a new twist on the path to harmony.Diabetes care, 35 12
M. Lazar (2005)
How Obesity Causes Diabetes: Not a Tall TaleScience, 307
(1980)
Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years
(1980)
Prevalence and incidence trends for diagnosed diabetes among adults aged
J. Schectman, J. Schorling, J. Voss (2008)
Appointment Adherence and Disparities in Outcomes Among Patients with DiabetesJournal of General Internal Medicine, 23
L. Geiss, Jing Wang, Yiling Cheng, T. Thompson, L. Barker, Yanfeng Li, A. Albright, E. Gregg (2014)
Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012.JAMA, 312 12
D. Sacks (2009)
The diagnosis of diabetes is changing: how implementation of hemoglobin A1c will impact clinical laboratories.Clinical chemistry, 55 9
(1990)
UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group.Metabolism: clinical and experimental, 39 9
Purpose:To examine the association between weight loss and type 2 diabetes remission among vulnerable populations living in medically underserved areas of the Mid-Southern United States.Design:Quantitative, retrospective cohort study.Setting:114 ambulatory sites and 5 adults’ hospitals in the Mid-South participating in a regional diabetes registry.Participants:9,900 adult patients with type 2 diabetes, stratified by remission status, with 1 year of baseline electronic medical record data, and 1 year of follow-up data for the 2015-2018 study period.Measures:The outcomes were diabetes remissions, categorized as any remission, partial remission, and complete remission based on the guidelines of the American Diabetes Association. The exposure was weight loss, calculated by the change in the Body Mass Index (BMI) as a proxy measure.Analysis:χ2 tests, Fisher’s exact tests, and the Mann-Whitney U-test were used to examine the differences in patient characteristics by remission status across the 3 remission categories, as appropriate. Multiple multivariable logistic regressions adjusting for confounders were performed to estimate the adjusted odds ratios (aORs) for the associations between weight loss and diabetes remission.Results:Among 9,900 patients identified, a reduction of 0.3 kg/m2 (standard deviation: 2.5) in the average BMI from the baseline to the follow-up was observed. 10.8% achieved any type of remission, with 9.8% for partial and 1.0% for complete remissions. Greater weight loss was significantly associated with an increased likelihood of any (aOR = 1.07, 95% confidence interval (CI), 1.06-1.08), partial (aOR 1.06, 95% CI, 1.04-1.07), and complete diabetes remission (aOR 1.10, 95% CI, 1.07-1.13).Conclusions:Weight loss is significantly associated with diabetes remission among patients living in medically underserved areas, but complete remission is rare.
American Journal of Health Promotion – SAGE
Published: Jan 1, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.